2023 - Research.com Medicine in Canada Leader Award
2012 - Fellow of the Royal Society of Canada Academy of Science
Steven A. Narod spends much of his time researching Breast cancer, Internal medicine, Oncology, Cancer and Ovarian cancer. His work carried out in the field of Breast cancer brings together such families of science as Odds ratio, Cancer research, Gynecology and Risk factor. In his work, Germline and Carcinoma is strongly intertwined with Germline mutation, which is a subfield of Internal medicine.
His Oncology study integrates concerns from other disciplines, such as Chemotherapy, Case-control study, Mammary gland, Mutation and Prospective cohort study. His research ties Surgery and Cancer together. His Ovarian cancer research integrates issues from Genetic counseling, Serous fluid and Disease, Age of onset.
His main research concerns Breast cancer, Internal medicine, Oncology, Cancer and Ovarian cancer. Steven A. Narod has included themes like Gynecology, Family history, Genetic testing and Risk factor in his Breast cancer study. The study incorporates disciplines such as Prophylactic Oophorectomy, Epidemiology and Obstetrics in addition to Gynecology.
In Oncology, Steven A. Narod works on issues like Germline mutation, which are connected to Germline. Steven A. Narod has researched Cancer in several fields, including CHEK2, Cancer research and Genotype. His Ovarian cancer research includes elements of Oophorectomy and Serous fluid.
His scientific interests lie mostly in Breast cancer, Internal medicine, Oncology, Cancer and Ovarian cancer. He is interested in BRCA mutation, which is a field of Breast cancer. His Internal medicine research focuses on Mutation and how it relates to Allele.
His study explores the link between Oncology and topics such as Germline mutation that cross with problems in Cancer research. Steven A. Narod works in the field of Cancer, namely Mastectomy. The concepts of his Ovarian cancer study are interwoven with issues in Oophorectomy, Gynecology and Serous fluid.
His primary areas of investigation include Internal medicine, Breast cancer, Oncology, Cancer and Ovarian cancer. His Internal medicine study typically links adjacent topics like Germline. Steven A. Narod combines subjects such as Genetic testing, Cohort study, Cohort and Hazard ratio with his study of Breast cancer.
His Oncology study incorporates themes from Epidemiology, Young adult, Mortality rate, Lymph and Metastasis. His biological study spans a wide range of topics, including Prospective cohort study and Bioinformatics. His Ovarian cancer research incorporates themes from Germline mutation, Gynecology, Serous fluid and Chemotherapy.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1
Yoshio Miki;Jeff Swensen;Donna Shattuck-Eidens;P. Andrew Futreal.
Triple-Negative Breast Cancer: Clinical Features and Patterns of Recurrence
Rebecca Dent;Maureen Trudeau;Kathleen I. Pritchard;Wedad M. Hanna.
Clinical Cancer Research (2007)
Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies
A. Antoniou;P.D.P. Pharoah;S. Narod;H.A. Risch.
American Journal of Human Genetics (2003)
Genetic Heterogeneity and Penetrance Analysis of the BRCA1 and BRCA2 Genes in Breast Cancer Families
D Ford;D F Easton;M Stratton;S Narod.
American Journal of Human Genetics (1998)
Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13
Richard Wooster;Susan L. Neuhausen;Jonathan Mangion;Yvette Quirk.
Risks of cancer in BRCA1-mutation carriers
Ford D;Easton Df;Bishop Dt;Narod Sa.
The Lancet (1994)
Prophylactic Oophorectomy in Carriers of BRCA1 or BRCA2 Mutations
Timothy R. Rebbeck;Henry T. Lynch;Susan L. Neuhausen;Steven A. Narod.
The New England Journal of Medicine (2002)
A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25
Rayjean J. Hung;James D. Mckay;Valerie Gaborieau;Paolo Boffetta.
Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination.
Ellen Warner;Donald B. Plewes;Kimberley A. Hill;Petrina A. Causer.
Bilateral Prophylactic Mastectomy Reduces Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers: The PROSE Study Group
Timothy R. Rebbeck;Tara Friebel;Henry T. Lynch;Susan L. Neuhausen.
Journal of Clinical Oncology (2004)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: